Prestige Wealth Management Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28
Closed -$1.93K 1009
2024
Q1
$1.93K Hold
28
﹤0.01% 751
2023
Q4
$2.07K Hold
28
﹤0.01% 731
2023
Q3
$1.91K Buy
28
+17
+155% +$1.44K ﹤0.01% 748
2023
Q2
$1.03K Buy
+11
New +$858 ﹤0.01% 906

Other funds holding EXAS

Prestige Wealth Management Group's EXAS Position: Q2 2024 in Review

Prestige Wealth Management Group sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 28 shares — an estimated $1.93K sold.

Prestige Wealth Management Group first reported a position in EXAS in Q2 2023 and held it in 4 quarters. The position peaked at $2.07K in Q4 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Prestige Wealth Management Group reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Prestige Wealth Management Group sold 28 Exact Sciences shares in Q2 2024, an estimated $1.93K.
  • Prestige Wealth Management Group first reported a position in Exact Sciences in Q2 2023 and held it in 4 quarters.
  • Prestige Wealth Management Group's Exact Sciences position peaked at $2.07K in Q4 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Prestige Wealth Management Group's 13F filing for Q2 2024, filed 6 Aug 2024.